STAT Plus: Pharmalittle: Biogen delays Alzheimer’s drug filing; BARDA head leaves amid shakeup
Rise and shine, everyone, another busy and challenging day is on the way. And though the days may seem to blur together lately, this is already the middle of the week. Depending on your perspective, this may be cause to acknowledge some progress, however modest, at forging ahead under difficult circumstances. So treat yourself to a cup of stimulation. Our own choice today is the ever-tasty maple bourbon. Meanwhile, here are some tidbits to guide you on your journey. Stay in touch and stay safe. …
Rick Bright, one of the nation’s leading vaccine development experts and the director of the Biomedical Advanced Research and Development Authority, is no longer leading the organization, STAT reports. The shakeup at the agency, known as BARDA, could not come at a more inopportune time for the office, which invests in drugs, devices, and other technologies that help address infectious disease outbreaks and which has been at the center of the government response to Covid-19.
